288 related articles for article (PubMed ID: 19756415)
21. Randomized, Controlled, Phase 2 Trial of Povidone-Iodine/Dexamethasone Ophthalmic Suspension for Treatment of Adenoviral Conjunctivitis.
Cinal A
Am J Ophthalmol; 2019 Jan; 197():184. PubMed ID: 30389099
[No Abstract] [Full Text] [Related]
22. A prospective randomized study to determine the efficacy of preoperative topical levofloxacin in reducing conjunctival bacterial flora.
Miño de Kaspar H; Kreutzer TC; Aguirre-Romo I; Ta CN; Dudichum J; Bayrhof M; Klauss V; Kampik A
Am J Ophthalmol; 2008 Jan; 145(1):136-142. PubMed ID: 17996212
[TBL] [Abstract][Full Text] [Related]
23. Correlation of Adenoviral Titers with Severity of Adenoviral Conjunctivitis and Time to Viral Clearance for 21 Days.
Morettin CE; Harthan JS; Huecker JB; Perera CD; Than T; Whiteside M; Johnson SD; Shorter E; Migneco MK; Olson CK; Alferez CS; Camp D; Hartwick ATE; Gordon MO
Optom Vis Sci; 2023 Mar; 100(3):187-193. PubMed ID: 36749104
[TBL] [Abstract][Full Text] [Related]
24. Randomized, Controlled, Phase 2 Trial of Povidone-Iodine/Dexamethasone Ophthalmic Suspension for the Treatment of Adenoviral Conjunctivitis.
Ramakrishnan S; Vempati J; Baskaran P
Am J Ophthalmol; 2019 Aug; 204():140. PubMed ID: 31235065
[No Abstract] [Full Text] [Related]
25. Randomized, Controlled, Phase 2 Trial of Povidone-Iodine/Dexamethasone Ophthalmic Suspension for Treatment of Adenoviral Conjunctivitis.
Pepose JS; Ahuja A; Liu W; Narvekar A; Haque R
Am J Ophthalmol; 2019 Sep; 205():197. PubMed ID: 31327463
[No Abstract] [Full Text] [Related]
26. Is it possible to detect the presence of adenovirus in conjunctiva before the onset of conjunctivitis?
Kimura R; Migita H; Kadonosono K; Uchio E
Acta Ophthalmol; 2009 Feb; 87(1):44-7. PubMed ID: 19178389
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of clinical efficacy and safety of tobramycin/dexamethasone ophthalmic suspension 0.3%/0.05% compared to azithromycin ophthalmic solution 1% in the treatment of moderate to severe acute blepharitis/blepharoconjunctivitis.
Torkildsen GL; Cockrum P; Meier E; Hammonds WM; Silverstein B; Silverstein S
Curr Med Res Opin; 2011 Jan; 27(1):171-8. PubMed ID: 21138337
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of indomethacin 0.1% and fluorometholone 0.1% on conjunctival inflammation following chronic application of antiglaucomatous drugs.
Baudouin C; Nordmann JP; Denis P; Creuzot-Garcher C; Allaire C; Trinquand C
Graefes Arch Clin Exp Ophthalmol; 2002 Nov; 240(11):929-35. PubMed ID: 12486516
[TBL] [Abstract][Full Text] [Related]
29. The Treatment Models for Adenoviral Keratoconjunctivitis in the Childhood Population.
Bekmez S; Eris E
Ocul Immunol Inflamm; 2021 Nov; 29(7-8):1627-1632. PubMed ID: 32643975
[No Abstract] [Full Text] [Related]
30. A randomized controlled trial of povidone-iodine/dexamethasone ophthalmic suspension for acute viral conjunctivitis.
Pepose JS; Narvekar A; Liu W; Haque R
Clin Ophthalmol; 2019; 13():535-544. PubMed ID: 30962674
[TBL] [Abstract][Full Text] [Related]
31. Randomized clinical trial of a new dexamethasone delivery system (Surodex) for treatment of post-cataract surgery inflammation.
Tan DT; Chee SP; Lim L; Lim AS
Ophthalmology; 1999 Feb; 106(2):223-31. PubMed ID: 9951469
[TBL] [Abstract][Full Text] [Related]
32. A randomized, double-masked, placebo-controlled parallel study of loteprednol etabonate 0.2% in patients with seasonal allergic conjunctivitis.
Shulman DG; Lothringer LL; Rubin JM; Briggs RB; Howes J; Novack GD; Hart K
Ophthalmology; 1999 Feb; 106(2):362-9. PubMed ID: 9951491
[TBL] [Abstract][Full Text] [Related]
33. A pilot study of 1 versus 3 days of dexamethasone as add-on therapy in children with streptococcal pharyngitis.
Niland ML; Bonsu BK; Nuss KE; Goodman DG
Pediatr Infect Dis J; 2006 Jun; 25(6):477-81. PubMed ID: 16732143
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of a Single Administration of 5% Povidone-Iodine in the Treatment of Adenoviral Conjunctivitis.
Than T; Morettin CE; Harthan JS; Hartwick ATE; Huecker JB; Johnson SD; Migneco MK; Shorter E; Whiteside M; Olson CK; Alferez CS; van Zyl T; Rodic-Polic B; Storch GA; Gordon MO
Am J Ophthalmol; 2021 Nov; 231():28-38. PubMed ID: 34102153
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of sampling technique and transport media for the diagnostics of adenoviral eye infections. Adenovirus sampling and transport.
Wölfel R; Pfeffer M; Essbauer S; Nerkelun S; Dobler G
Graefes Arch Clin Exp Ophthalmol; 2006 Nov; 244(11):1497-504. PubMed ID: 16550405
[TBL] [Abstract][Full Text] [Related]
36. A comparison of the relative efficacy and clinical performance of olopatadine hydrochloride 0.1% ophthalmic solution and ketotifen fumarate 0.025% ophthalmic solution in the conjunctival antigen challenge model.
Berdy GJ; Spangler DL; Bensch G; Berdy SS; Brusatti RC
Clin Ther; 2000 Jul; 22(7):826-33. PubMed ID: 10945509
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness of oral dexamethasone in the treatment of moderate to severe pharyngitis in children.
Olympia RP; Khine H; Avner JR
Arch Pediatr Adolesc Med; 2005 Mar; 159(3):278-82. PubMed ID: 15753273
[TBL] [Abstract][Full Text] [Related]
38. Topical corticosteroids reverse the antiviral effect of topical cidofovir in the Ad5-inoculated New Zealand rabbit ocular model.
Romanowski EG; Araullo-Cruz T; Gordon YJ
Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):253-7. PubMed ID: 9019458
[TBL] [Abstract][Full Text] [Related]
39. Efficacy comparison between povidone iodine 2.5% and tetracycline 1% in prevention of ophthalmia neonatorum.
David M; Rumelt S; Weintraub Z
Ophthalmology; 2011 Jul; 118(7):1454-8. PubMed ID: 21439642
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic accuracy of clinical signs, symptoms and point-of-care testing for early adenoviral conjunctivitis.
Shorter ES; Whiteside MM; Harthan JS; Morettin CE; Perera CD; Johnson SD; Migneco MK; Huecker JB; Hartwick ATE; Than TP; Gordon MO
Clin Exp Optom; 2022 Sep; 105(7):702-707. PubMed ID: 34751088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]